cohen Jeffrey k's Form 4/A amendment
AmendedAspira Women's Health Inc. (AWHL) · filed May 29, 2026
- Accession no.
- 0001493152-26-026345
- Filed
- May 29, 2026, 4:05 PM ET
- Trade date
- Sep 17, 2025
- Filing delay
- 254 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Sep 19, 2025
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $25.0K. It was filed 254 days after the trade.
This amendment replaces 0001493152-25-014333 (filed Sep 19, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| cohen Jeffrey kCIK 0002071174 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2025 | Common Stock | PPurchaseAcquired | +55,556 | $0.45 | +$25,000.2 | 374,906 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2025 | Common Stock, par value $0.001 | PPurchaseAcquired | +41,667 | $0.00 | $0 | 41,667 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This report is being filed to correct the number and nature of shares held by Dr. Cohen on September 17, 2025, the number of shares held by Dr. Cohen's spouse on September 17, 2025 and the presentation of the warrants held on September 17, 2025.